Personal information

Activities

Collapse all

Employment (4)

Michigan State University: East Lansing, MI, US

2021-02-01 to present | Research Associate (Radiology)
Employment
Source: Self-asserted source
Saumya Nigam

RML Mehrotra Pathology: Lucknow, Uttar Pradesh, IN

2019-09-16 to 2019-11-13 | Trainee (Molecular Genetics)
Employment
Source: Self-asserted source
Saumya Nigam

University of Nebraska Medical Center: Omaha, NE, US

2017-05-09 to 2018-07-08 | Postdoctoral Research Associate (Pharmacology and Experimental Neuroscience)
Employment
Source: Self-asserted source
Saumya Nigam

Indian Institute of Technology Bombay: Mumbai, Maharashtra, IN

2007-09-10 to 2009-12-31 | Junior Research Fellow (Metallurgical Engineering & Materials Science)
Employment
Source: Self-asserted source
Saumya Nigam

Education and qualifications (2)

IITB-Monash Research Academy: Mumbai, Maharashtra, IN

2010-01-04 to 2016-10-24 | PhD
Education
Source: Self-asserted source
Saumya Nigam

Allahabad Agricultural Institute Deemed University: Allahabad, Uttar Pradesh, IN

2003-07 to 2007-07 | Bachelors in Technology (B Tech) (Biotechnology)
Qualification
Source: Self-asserted source
Saumya Nigam

Professional activities (1)

World Molecular Imaging Society: Culver City, California, US

2022-08 to present (Department of Radiology)
Membership
Source: Self-asserted source
Saumya Nigam

Peer review (25 reviews for 14 publications/grants)

Review activity for ACS omega. (1)
Review activity for Cells. (1)
Review activity for Colloids and surfaces. (2)
Review activity for International journal of molecular sciences. (1)
Review activity for Journal of magnetism and magnetic materials. (2)
Review activity for Journal of materials chemistry. (2)
Review activity for Materials today communications. (1)
Review activity for Micromachines. (2)
Review activity for Molecules. (1)
Review activity for Nanomaterials. (2)
Review activity for Pharmaceutics. (1)
Review activity for RSC advances (2)
Review activity for RSC medicinal chemistry. (1)
Review activity for Technology in cancer research & treatment. (6)
How many people are using ORCID?